Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™

Product News   Sep 12, 2014

 
Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Synpromics Awarded Innovate UK Grant to Evaluate its Inducible Promoter Platform

Product News

Synpromics Ltd, the leader in gene control, announces a partnership with Lonza Pharma & Biotech to further develop its inducible promoter system and improve manufacturing of biopharmaceuticals. The 18-month project has been made possible through the award of a £235,000 grant, part of the medicines manufacturing competition from Innovate UK.

READ MORE

Fusion Pharmaceuticals Licenses Isogenica’s CIS Display Technology

Product News

Technology will be used to progress Fusion’s pipeline of alpha therapeutics for the treatment of cancers.

READ MORE

QIAGEN Announces European Launch of QIAstat-Dx

Product News

Posters by early adopters demonstrate accurate, fast, cost-effective and flexible diagnosis of syndromic infections and other diseases in unique and versatile Sample to Insight workflows.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE